Newly developed anti-angiogenic therapy in non-small cell lung cancer

Angiogenesis and its role in the growth and development of non-small cell lung cancer (NSCLC) metastases has become an increasing clinical problem. Vascular endothelial growth factor (VEGF) plays a key role in advanced NSCLC. To some extent, anti-angiogenic therapies acquired some efficacy in combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Jingjing, Zhang, Yongchang, Chen, Xue, Yang, Haiyan, Zhou, Chunhua, Yang, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839380/
https://www.ncbi.nlm.nih.gov/pubmed/29515799
http://dx.doi.org/10.18632/oncotarget.23755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839380/
https://www.ncbi.nlm.nih.gov/pubmed/29515799
http://dx.doi.org/10.18632/oncotarget.23755

Ejemplares similares